de la Rosa R - Search Results

1

Provider bias in the selection of non-nucleoside reverse transcriptase inhibitor and protease inhibitor-based highly active antiretroviral therapy and HIV treatment outcomes in observational studies.

Wood E, Hogg RS, Heath KV, de la Rosa R, Lee N, Yip B, O'Shaughnessy MV, Montaner JS. Wood E, et al. Among authors: de la rosa r. AIDS. 2003 Dec 5;17(18):2629-34. doi: 10.1097/00002030-200312050-00010. AIDS. 2003. PMID: 14685057

2

HIV-1 drug resistance: degree of underestimation by a cross-sectional versus a longitudinal testing approach.

Harrigan PR, Wynhoven B, Brumme ZL, Brumme CJ, Sattha B, Major JC, de la Rosa R, Montaner JS. Harrigan PR, et al. Among authors: de la rosa r. J Infect Dis. 2005 Apr 15;191(8):1325-30. doi: 10.1086/428852. Epub 2005 Mar 16. J Infect Dis. 2005. PMID: 15776380

3

Life-threatening reaction after first ever dose of abacavir in an HIV-1-infected patient.

de la Rosa R, Harris M, Uyeda L, Goodison K, Keown P, Montaner JS. de la Rosa R, et al. AIDS. 2004 Feb 20;18(3):578-9. doi: 10.1097/00002030-200402200-00032. AIDS. 2004. PMID: 15090818 No abstract available.

4

Endogenous IL-7 is associated with increased thymic volume in adult HIV-infected patients under highly active antiretroviral therapy.

Ruiz-Mateos E, de la Rosa R, Franco JM, Martinez-Moya M, Rubio A, Soriano N, Sanchez-Quijano A, Lissen E, Leal M. Ruiz-Mateos E, et al. Among authors: de la rosa r. AIDS. 2003 May 2;17(7):947-54. doi: 10.1097/00002030-200305020-00002. AIDS. 2003. PMID: 12700443

5

Long-term virological outcome and resistance mutations at virological rebound in HIV-infected adults on protease inhibitor-sparing highly active antiretroviral therapy.

de la Rosa R, Ruíz-Mateos E, Rubio A, Abad MA, Vallejo A, Rivero L, Genebat M, Sánchez-Quijano A, Lissen E, Leal M. de la Rosa R, et al. J Antimicrob Chemother. 2004 Jan;53(1):95-101. doi: 10.1093/jac/dkh012. Epub 2003 Dec 4. J Antimicrob Chemother. 2004. PMID: 14657091 Clinical Trial.

6

Thymic volume is associated independently with the magnitude of short- and long-term repopulation of CD4+ T cells in HIV-infected adults after highly active antiretroviral therapy (HAART).

Ruiz-Mateos E, Rubio A, Vallejo A, De la Rosa R, Sanchez-Quijano A, Lissen E, Leal M. Ruiz-Mateos E, et al. Among authors: de la rosa r. Clin Exp Immunol. 2004 Jun;136(3):501-6. doi: 10.1111/j.1365-2249.2004.02474.x. Clin Exp Immunol. 2004. PMID: 15147352 Free PMC article.

7

Influence of highly active antiretroviral therapy on the outcome of subclinical visceral leishmaniasis in human immunodeficiency virus-infected patients.

de la Rosa R, Pineda JA, Delgado J, Macías J, Morillas F, Martín-Sánchez J, Leal M, Sánchez-Quijano A, Lissen E. de la Rosa R, et al. Clin Infect Dis. 2001 Feb 15;32(4):633-5. doi: 10.1086/318708. Epub 2001 Feb 6. Clin Infect Dis. 2001. PMID: 11181128

8

Incidence of and risk factors for symptomatic visceral leishmaniasis among human immunodeficiency virus type 1-infected patients from Spain in the era of highly active antiretroviral therapy.

de La Rosa R, Pineda JA, Delgado J, Macías J, Morillas F, Mira JA, Sánchez-Quijano A, Leal M, Lissen E. de La Rosa R, et al. J Clin Microbiol. 2002 Mar;40(3):762-7. doi: 10.1128/JCM.40.3.762-767.2002. J Clin Microbiol. 2002. PMID: 11880390 Free PMC article.

9

Baseline thymic volume is a predictor for CD4 T cell repopulation in adult HIV-infected patients under highly active antiretroviral therapy.

de la Rosa R, Leal M, Rubio A, Martinez-Moya M, Delgado J, Ruíz-Mateos E, Merchante E, Sánchez-Quijano A, Eduordo L; Viral Hepatitis and AIDS Study Group. de la Rosa R, et al. Antivir Ther. 2002 Sep;7(3):159-63. Antivir Ther. 2002. PMID: 12487382

10

Long-term suppression of plasma viremia with highly active antiretroviral therapy despite virus evolution and very limited selection of drug-resistant genotypes.

Pariente N, Pernas M, de la Rosa R, Gómez-Mariano G, Fernández G, Rubio A, López M, Benito JM, López-Galíndez C, Leal M, Domingo E, Martinez MA, Mas A. Pariente N, et al. Among authors: de la rosa r. J Med Virol. 2004 Jul;73(3):350-61. doi: 10.1002/jmv.20098. J Med Virol. 2004. PMID: 15170628

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

125 results

Search Page

Filters